Scopolamine chemical structure
Find information on thousands of medical conditions and prescription drugs.

Hyoscine

Scopolamine, also known as hyoscine, is a tropane alkaloid drug obtained from plants of the Solanaceae family (Nightshade), such as henbane or jimson weed (Datura stramonium). It is part of the secondary metabolites of plants. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
Habitrol
Halcion
Haldol
Haloperidol
Halothane
Heparin sodium
Hepsera
Herceptin
Heroin
Hetacillin
Hexachlorophene
Hexal Diclac
Hexal Ranitic
Hexetidine
Hibiclens
Histidine
Hivid
HMS
Hyalgan
Hyaluronidase
Hycodan
Hycomine
Hydralazine
Hydrochlorothiazide
Hydrocodone
Hydrocortisone
Hydromorphone
Hydromox
Hydroxycarbamide
Hydroxychloroquine
Hydroxystilbamidine
Hydroxyzine
Hyoscine
Hypaque
Hytrin
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

It is structurally similar to the neurotransmitter acetylcholine and acts by blocking the muscarinic acetylcholine receptors; it is thus classified as an anticholinergic.

In medicine, it is usually used in the form scopolamine hydrobromide. It can be used as a depressant of the central nervous system, though it can cause delirium in the presence of pain, mydriasis (pupillary dilation), and cycloplegia (paralysis of the eye muscles). When combined with morphine, it produces a tranquilized state known as twilight sleep and amnesia. Although originally used in obstetrics it is now considered dangerous.

It is used in ophthalmology to deliberately cause cycloplegia and mydriasis so that certain diagnostic procedures may be performed. It is also used in the treatment of iridocyclitis.

In otolaryngology it has been used to ease the trauma of intubation.

It is also an antiemetic (prevents vomiting), antivertigo (prevents dizziness), and antispasmodic (reduces smooth muscle contractions; although a derivate called butylscopolamine, that does not cross the BBB, is used preferably). It can be used as a pre-anesthetic sedation, as an antiarrhythmic (preventing irregular heartbeat) during anesthesia, and for the prevention of motion sickness.

The drug is highly toxic and has to be used in minute doses. An overdose can cause delirium, delusions, paralysis, stupor and death.

The use of scopolamine as a truth drug was investigated by various intelligence agencies, including the CIA, during the 50s. see:Project MKULTRA. It was found that, due to the hallucinogenic side effects of the drug, the truth was prone to distortion, and the project was subsequently abandoned.

Scopolamine is used criminally as a date rape drug and as an aid to robbery, the most common act being the clandestine drugging of a victim's drink. It is preferred because it induces retrograde amnesia, or an inability to recall events prior to its administration. Victims of this crime are often admitted to a hospital in police custody, under the assumption that the patient is experiencing a psychotic episode. A telltale sign is a fever accompanied by a lack of sweat.

In Colombia a plant admixture containing scopolamine called Burundanga has been used shamanically for decades. In recent years its criminal use (as outlined above) has become an epidemic. Approximately fifty percent of emergency room admissions for poisoning in Bogotá have been attributed to scopolamine.

Due to its effectiveness against sea-sickness it has become commonly used by scuba divers. However, this has lead to the discovery of another side effect. In deep water, below 50-60 feet, some divers have reported pain in the eyes, but the pain subsides quickly if the diver ascends to a depth of 40 feet or less. No study has been reported regarding the drug's effect on intra-ocular pressure or its effect on the eye's ability to adjust to pressure, so the medication should be used with extra caution among divers who intend to go below 50 feet.

Read more at Wikipedia.org


[List your site here Free!]


One nation's victory for sanity over alternative medicine - Australia
From Skeptical Inquirer, 9/1/03 by Barry Williams

What began as either an act of carelessness or a deliberate attempt to flout regulations by a manufacturer has resulted in a furor that calls into question the future of the entire "complementary medicine" industry in Australia.

Australia has a two-tiered regulation system for health-related devices, medicines, and food supplements, administered by the Therapeutic Goods Administration (TGA--the Australian counterpart of the Food and Drug Administration). It requires all prescription, plus some non-prescription pharmacy medicines (paracetamol, aspirin, etc.) to be "registered" together with evidence of their safety, quality control in manufacture, and efficacy. Other items, those that are considered to present lower levels of risk, are "listed," requiring only evidence of safety and quality control. The overwhelming proportion of complementary medicines, vitamins, minerals, and food supplements sold in Australia are listed items. All products are required to display on their packaging either an AustR(egistered) or AustL(isted) number, indicating the level at which they are regulated.

In January 2003, TGA was notified of serious illnesses suffered by some eighty people (nineteen requiring hospitalization) who had taken a popular travel sickness preventative medicine, Travacalm, a Registered product. Concerned by this, TGA conducted an analysis of Travacalm purchased from a pharmacy, revealing that tablets in one package contained amounts of the active ingredient, hyoscine, varying between none at all and seven times the safe dosage.

These alarming results caused TGA to conduct an immediate audit of the manufacturer, Pan Pharmaceuticals Ltd., to test its compliance with regulations. Pan, a listed public company, makes and markets a wide variety of complementary healthcare products under its own brand names, as well as being a contract manufacturer for several other companies. The audit found serious quality control failures in the process, along with other faulty manufacturing practices that rang alarm bells. TGA then expanded its audit to all products manufactured by the company, including not only its relatively small range of Registered products, but also its far larger range of Listed items. At that stage, Pan was the manufacturer of a high proportion of listed supplements and medicines sold in Australia, as well as others for export to forty countries.

Charging Pan with unacceptable manufacturing procedures, inadequate quality control, falsification of records, and other misdemeanors, TGA revoked its license to manufacture in April 2003. It then instituted an immediate compulsory product recall of (at last count and ongoing) more than 1,500 products, by far the largest recall of health-related (or any other) products in the nation's history. Several companies marketing products made by Pan, but sold under their own brand names, were caught in the net, with fourteen who failed to comply with TGA reporting procedures also having their licenses revoked.

Consternation, verging on panic, reigned throughout the entire alternative health industry. Health food shops and pharmacies denuded their shelves of suspect vitamin, herbal, and mineral supplements; spokespeople for the alternative/ complementary healthcare industry took to the newspapers and the airwaves in serried ranks, aiming blame at the regulators, the government, the medical "establishment," multinational pharmaceutical companies, and anyone else who they thought appropriate; lawsuits were launched in all directions; bewildered consumers stopped taking their (often self-prescribed) pills and besieged their suppliers demanding refunds. To date, no cases have been reported of anyone suffering any ill effects from ceasing to take their pills.

Aided by an unfortunate relaxation of the advertising regulations for healthcare products, sales of complementary medicines have undergone massive increases in the past five years, with a 2001 study conducted by Adelaide University suggesting that they amounted to $2.4 billion (Australian) per year. Once the staple of health food stores, they have since become major sellers in pharmacies, some of which display a whole wall of assorted varieties of snake-oil remedies. With that much money at stake, it is hardly surprising that the level of complaint from the industry was high.

The spin they sought to put on the facts was higher still. Representatives of the industry lobby group the Complementary Healthcare Council (made up of manufacturers, resellers, and "alternative" practitioners) approached the Federal Government, seeking a grant of $11 million of taxpayers' money to fund "public education on the benefits of complementary health supplements." Amazed at the sheer effrontery of this claim, Australian Skeptics immediately countered with a petition to its local Member of Parliament, requesting that no such funds be allocated, suggesting rather that any available money would be better spent on educating the public that most supplements were unnecessary and many other complementary medicines were untested for efficacy. (As our local MP is both a medical practitioner and the Federal Minister for Education, we felt we were on firm ground.)

Then things went from bad to worse for the industry. While the media interest was at its height, the Premier of New South Wales, Hon. Bob Carr MP, appeared on TV saying, "... it appears that most of these products give no more benefit than colored water"; a national TV science program, Catalyst, aired a report on their investigation into various herbal remedies, which showed wide variations in the amount of active ingredient and lack of uniformity in many preparations; the chairman of the Australian Olympic Committee, John Coates (alert to the threat posed to athletes by inadvertent ingestion of proscribed substances), called for much sterner regulation of the labeling of supplements.

More important, it now seems that Australian Skeptics' long years of advocacy that providers of "alternative" medicine be held to no lower standards of accountability than apply to orthodox medicine might at last bear fruit. The government has introduced legislation requiring a much higher degree of compliance, evidence of efficacy, and accuracy in labeling for manufacturers of complementary medicines, with very large financial penalties for noncompliance. Further, it has announced an inquiry into the entire alternative medicine industry, to report to Parliament within three months. Sanity might just stand a chance.

One final lighter note. During the media frenzy a group of enterprising orchardists placed advertisements in metropolitan newspapers. Showing simply a picture of a shiny red apple, it bore the cogent caption, "The Alternative to Alternative Medicine." We couldn't have put it better ourselves.

Barry Williams is Executive Officer of Australian Skeptics Inc., Roseville, NSW, Australia. E-mail: skeptics@kasm.com.au; Web site: www.skeptics.com.au.

COPYRIGHT 2003 Committee for the Scientific Investigation of Claims of the Paranormal
COPYRIGHT 2003 Gale Group

Return to Hyoscine
Home Contact Resources Exchange Links ebay